This analysis utilized a multivariable logistic regression model to evaluate factors influencing the reporting of ocular toxicity events in breast cancer patients, considering age, type of CDK4/6 inhibitor, number of concomitant medications, and whether letrozole was used concomitantly. This evidence concerns the gene CDK4 and breast cancer.